Neuromuscular Depolarizing Agents
"Neuromuscular Depolarizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation.
| Descriptor ID |
D009467
|
| MeSH Number(s) |
D27.505.696.663.700.710.550
|
| Concept/Terms |
Neuromuscular Depolarizing Agents- Neuromuscular Depolarizing Agents
- Agents, Neuromuscular Depolarizing
- Depolarizing Agents, Neuromuscular
- Depolarizing Blockers
- Blockers, Depolarizing
- Depolarizing Muscle Relaxants
- Relaxants, Depolarizing Muscle
- Muscle Relaxants, Depolarizing
|
Below are MeSH descriptors whose meaning is more general than "Neuromuscular Depolarizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Neuromuscular Depolarizing Agents".
This graph shows the total number of publications written about "Neuromuscular Depolarizing Agents" by people in this website by year, and whether "Neuromuscular Depolarizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuromuscular Depolarizing Agents" by people in Profiles.
-
Extreme variability in succinylcholine dose for muscle relaxation in electroconvulsive therapy. Australas Psychiatry. 2018 Aug; 26(4):391-393.
-
Safe resumption of maintenance electroconvulsive therapy 12 days after surgical repair of hip fracture. J ECT. 2015 Jun; 31(2):81-2.
-
Proteomic Analysis of Plasma from California Sea Lions (Zalophus californianus) Reveals Apolipoprotein E as a Candidate Biomarker of Chronic Domoic Acid Toxicosis. PLoS One. 2014; 10(4):e0123295.
-
Characterization of renal toxicity in mice administered the marine biotoxin domoic Acid. J Am Soc Nephrol. 2014 Jun; 25(6):1187-97.
-
Comparison of muscle paralysis after intravenous and intraosseous administration of succinylcholine in Swine. J Spec Oper Med. 2014; 14(2):35-37.
-
Methohexital and succinylcholine dosing for electroconvulsive therapy (ECT): actual versus ideal. J ECT. 2012 Sep; 28(3):e29-30.
-
Rocuronium as muscle relaxant for electroconvulsive therapy in a patient with adult-onset muscular dystrophy. J ECT. 2011 Dec; 27(4):e63-4.
-
Prolonged succinylcholine action during electroconvulsive therapy (ECT) after cytarabine, vincristine, and rituximab chemotherapy. J ECT. 2011 Mar; 27(1):e42-3.
-
The effect of muscle relaxants on cricothyroid muscle: a report of three cases. Anesth Analg. 1996 Mar; 82(3):657-60.
-
Differential effects of nitric oxide gas and nitric oxide donors on depolarization-induced release of [3H]norepinephrine from rat hippocampal slices. Neuropharmacology. 1994 Nov; 33(11):1367-74.